Award - World Trade Center Health Program - Survivor Clinical Center of Excellence
CDC · CDC OFFICE OF ACQUISITION SERVICES
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation CDC-75D301-WTCHP-Award in this department, oldest first.
- Sep 30, 2025 · this noticeAward NoticeNEW YORK CITY HEALTH AND HOSPITALS CORPORATION · $165.9M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
On September 26, 2025, the Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, awarded Contract No. 75D301-25-C-20641 on behalf of the National Institute for Occupational Safety and Health (NIOSH) / World Trade Center Health Program (WTCHP) to the New York City Health and Hospitals Corporation. The contract establishes a Survivor Clinical Center of Excellence (CCE) to provide healthcare services, including health monitoring, diagnosis, and treatment, to current and future eligible Survivors of the September 11, 2001 (9/11) terrorist attacks residing in the New Yor… (show all)
k Metropolitan Area. The contract is awarded as cost-reimbursable (no fee or profit) with a total estimated cost ceiling of $165,914,538, covering a base performance period from September 29, 2025, to September 28, 2026, with four additional 12-month option periods. The WTCHP is authorized by Title I of the James Zadroga 9/11 Health and Compensation Act of 2010 (Zadroga Act) and is a limited health benefit program, meaning that treatment is only available for specific covered health condition(s) for which exposure to airborne toxins, any other hazard, or any other adverse condition resulting from the 9/11, terrorist attacks has been determined to be substantially likely to be a significant factor in aggravating, contributing to, or causing the illness or health condition in an individual member. The Program is administered by the NIOSH, part of the CDC, a component of the Department of Health and Human Services, and provides medical monitoring, screening, and treatment for Program members. Members comprise of Responders to the 9/11 terrorist attacks in New York City (NYC), Responders at the Pentagon and near Shanksville, Pennsylvania, and Survivors in the NYC Disaster Area.
Recent Agency Awards (Loose Match)
110 award notices on SAM.gov in the last 24 months. Matched by: Same agency (CDC), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (106): middle half $240K to $6.8M, median $781K; range $14K to $4.5B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| POLOLEI SOLUTIONS, LLC | 5 | $3.3M | Jul 21, 2026 |
| GLAXOSMITHKLINE, LLC | 3 | $1.7B | Mar 27, 2026 |
| RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA | 3 | $9.8M | Jun 4, 2026 |
| MERCK SHARP & DOHME LLC · $MRK · $66.6B | 2 | $4.5B | Sep 14, 2026 |
| Pfizer New York NY 10001 USA | 2 | $1.2B | Jun 3, 2026 |
| SEQIRUS USA INC | 2 | $663.9M | Dec 31, 2024 |
| Moderna Princeton NJ 08540 USA | 2 | $314.2M | Jun 3, 2026 |
| SANOFI PASTEUR INC. | 2 | $233.3M | Dec 31, 2024 |
| ASTRAZENECA PHARMACEUTICALS LP | 2 | $61.0M | Dec 31, 2024 |
| Sanofi Swiftwater PA 18370 USA | 2 | $40.6M | Jun 3, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $MRK reported $66.6B revenue (12 months to Jun 30, 2026). The median single-winner award in these 106 past awards, $781K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Sep 28, 2026SPN SOLUTIONS INC$992KModernized VAERS Reporting ApplicationNo listed company matched (Materiality N/A)
- Sep 28, 2026PREMIER HEALTHCARE SOLUTIONS, INC$4.2MComprehensive Encounter-level Inpatient and Hospital-based Outpatient Billing and Chargemaster Database for Addressing Public Health PrioritiesNo listed company matched (Materiality N/A)
- Sep 21, 2026Precision Delivery Federal LLC$296KMarket forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxisNo listed company matched (Materiality N/A)
- Sep 15, 2026NEW TECH SOLUTIONS, INC.$195KNetwork Analysis ToolNo listed company matched (Materiality N/A)
- Sep 14, 2026MERCK SHARP & DOHME LLC$9.5MMerck Stockpile Vaccine Storage and Rotation ContractMateriality: 0.01% of $MRK revenue (Low) SEC
- Sep 11, 2026Johnson Controls Building Automation Systems, LLC$1.9MCCURE PACS Software Support Agreement (Smart Cards)No listed company matched (Materiality N/A)
- Sep 9, 2026DECISIONPOINT CORPORATION$28.1MDEO/ORR All Hazards Labor SupportNo listed company matched (Materiality N/A)
- Aug 31, 2026RELI GROUP INC$2.2MRisk Management Framework and Cloud Security Operations Support ServicesNo listed company matched (Materiality N/A)
- Aug 24, 2026BANYAN COMMUNICATIONS, INC.$2.5MDFWED Communication ServicesNo listed company matched (Materiality N/A)
- Jul 28, 2026MANHATTAN TORCON A JOINT VENTURE Arlington VA 22201 USA$491.8MConstruction of High-Containment Continuity Laboratory, Building 28 - CDC Roybal Campus, Atlanta, GANo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (5 filings)
- 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
- $99K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.